Tumors are one of the main causes of death in humans. The development of safe and effective methods for early diagnosis and treatment of tumors is a difficult problem that needs to be solved urgently. It is well established that the occurrence of tumors involves complex biological mechanisms, and the tumor microenvironment (TME) plays an important role in regulating the biological behavior of tumors. Cancer-associated fibroblasts (CAFs) are a group of activated fibroblasts with significant heterogeneity and plasticity in the tumor microenvironment. They secrete a variety of active factors to regulate tumor occurrence, development, metastasis, and therapeutic resistance. Although most studies suggest that CAFs have significant tumor-promoting functions, some evidence indicates that they may have certain tumor-suppressive functions in the early stage of tumors. Current research on CAFs continues to face many challenges, and the heterogeneity of their origin, phenotype, and function is a major difficulty and hot spot. To provide new perspectives for the research on CAFs and tumor diagnosis and treatment, this review summarizes the definition, origin, biomarkers, generation mechanism, functions, heterogeneity, plasticity, subpopulations, pre-metastasis niches (PMN), immune microenvironment, and targeted therapy of CAFs, describes the research progress and challenges, and proposes possible future research directions based on existing reports.

Disseminated superficial actinic porokeratosis (DSAP) is an autosomal dominantly inherited epidermal keratinization disorder whose etiology remains unclear. We performed exome sequencing in one unaffected and two affected individuals from a DSAP family. The mevalonate kinase gene (MVK) emerged as the only candidate gene located in previously defined linkage regions after filtering against existing SNP databases, eight HapMap exomes and 1000 Genomes Project data and taking into consideration the functional implications of the mutations. Sanger sequencing in 57 individuals with familial DSAP and 25 individuals with sporadic DSAP identified MVK mutations in 33% and 16% of these individuals (cases), respectively. All 14 MVK mutations identified in our study were absent in 676 individuals without DSAP. Our functional studies in cultured primary keratinocytes suggest that MVK has a role in regulating calcium-induced keratinocyte differentiation and could protect keratinocytes from apoptosis induced by type A ultraviolet radiation. Our results should help advance the understanding of DSAP pathogenesis.

No abstract

No abstract

Electrochromic multilayer films consisting of polyoxometalate (POM) cluster alpha-K(10)[P(2)W(17)O(61)].17H(2)O (P(2)W(17)), copper(II) complex [Cu(II)(phen)(2)](NO(3))(2) (phen = 1,10-phenithroline), and iron complex [Fe(II)(phen)(3)](ClO(4))(2) were fabricated on silicon, quartz and ITO substrates by layer-by-layer self-assembly method. The multilayer films, PSS/Cu(II)(phen)(2)/[(P(2)W(17)/Cu(II)(phen)(2))](n) and PSS/Fe(II)(phen)(3)/[(P(2)W(17)/Fe(II) (phen)(3))](n) were characterized by UV-vis spectra, X-ray photoelectron spectra, cyclic voltammetry (CV), chronoamperometric (CA) and in-situ spectral electrochemical measurements. The interesting feature of the electrochromic film is its adjustable color by reduction of both transition metal complex and polyoxometalate at different potentials. The multilayer films also exhibit high optical contrast, suitable response time and low operation potential due to the presence of mono-lacunary-substituted polyoxometalate and transition metal complex. This is the first example that the color of electrochromic film can be adjustable, which gives valuable information for exploring new electrochromic materials with tunable colors.